Suchergebnisse - "Roeker, Lindsey E"

PubPharm (5)

1

Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients

enthalten in: Haematologica | 2023

von Laracy, J. | Yan, J. | Steiger, S. | +14

2

Novel-agent combination therapies in chronic lymphocytic leukemia : the law of relative contributions

enthalten in: Haematologica | 2022

von Mato, A. | Roeker, L.

CommentOn: Haematologica. 2022 Sep 01;107(9):2108-2120. - PMID 35021599

3

All in the family : back-to-back kinase inhibitors for the treatment of chronic lymphocytic Leukemia

enthalten in: Haematologica | 2021

von Thompson, M. | Roeker, L. | Mato, A.

CommentOn: Haematologica. 2021 Sep 01;106(9):2364-2373. - PMID 33730844

4

Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia

enthalten in: Haematologica | 2021

von Eyre, T. | Lamanna, N. | Roeker, L. | +27

5

Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States

enthalten in: Haematologica | 2018

von Mato, A. | Thompson, M. | Allan, J. | +45

1
[1]